![](/img/cover-not-exists.png)
A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG)
Michal Yalon, Brian Rood, Tobey J. MacDonald, Geoff McCowage, Rochelle Kane, Shlomi Constantini, Roger J. PackerVolume:
aop
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/pbc.24142
File:
PDF, 147 KB
english, 2012